Juvenile Diabetes Mellitus (Type 1 Diabetes Mellitus - T1DM)

Definition and Terminology

• Fischer's Mastery of Surgery 8e; Robbins & Kumar Basic Pathology

Stages of Development

• Robbins & Kumar Basic Pathology

Pathogenesis

Genetic Susceptibility

• Over 20 susceptibility loci identified by genome-wide association studies
• Strongest association: MHC class II HLA-DR genes - 90-95% of European-descent T1DM patients carry HLA-DR3 and/or DR4 (vs. ~40% of unaffected subjects); 40-50% of patients are DR3/DR4 heterozygotes vs. only 5% of unaffected individuals
• Additional susceptibility: polymorphisms in CTLA4, PTPN22 (both inhibit T-cell responses - loss-of-function alleles promote excessive T-cell activation), and the insulin gene (VNTR polymorphisms reduce thymic insulin expression, impairing elimination of autoreactive T cells)

Immune Mechanism

• Fundamental defect: failure of self-tolerance in T cells specific for β-cell antigens
• Mechanism: defective deletion of self-reactive T cells in thymus (central tolerance) + abnormal regulatory T cells (peripheral tolerance)
• Destruction mediated by cytotoxic T cells (CD8+) reacting against β-cell antigens (Type IV hypersensitivity)
• Autoantibodies detected against: insulin, glutamic acid decarboxylase (GAD65), tyrosine phosphatases IA-2 and IA-2β, and ZnT8 - found in 85-90% of patients; these are markers but not the primary effectors of damage
• Histology: "insulitis" - lymphocytic infiltration (T cells and macrophages) with β-cell necrosis

Environmental Triggers

• Viral infections (notably coxsackievirus) have been implicated
• Microbiome changes may play a role
• Their exact mechanisms remain unclear
• Robbins & Kumar Basic Pathology; Symptom to Diagnosis 4e

Comparison: T1DM vs T2DM

• Robbins Cotran & Kumar Pathologic Basis of Disease; Robbins & Kumar Basic Pathology

Risk Factors and Genetics

• General population risk: 0.4%
• Siblings/children of affected: 5-6%
• Monozygotic twins: ~30-50% concordance (demonstrating both genetic and environmental contributions)
• First-degree relatives: up to 10% chance of development
• Associated autoimmune conditions: autoimmune thyroid disease, Addison disease, vitiligo, celiac disease, autoimmune hepatitis, myasthenia gravis, pernicious anemia
• Symptom to Diagnosis 4e; Thompson & Thompson Genetics 9e

Clinical Presentation

• Polyuria - osmotic diuresis from glucosuria
• Polydipsia - compensatory thirst
• Weight loss - despite polyphagia; due to loss of glucose in urine and catabolism

• Caused by the marked rise in the glucagon-to-insulin ratio with elevated cortisol
• Activates hormone-sensitive lipase → free fatty acid release → ketone body accumulation → metabolic acidosis
• Symptoms: excessive thirst, polyuria, nausea, vomiting, abdominal pain, weakness, altered consciousness (Kussmaul breathing, fruity breath)

Diagnosis

• T1DM-specific workup: positive islet autoantibodies (anti-GAD65, anti-IA2, anti-ZnT8), low/absent C-peptide
• HLA typing in selected cases
• Robbins & Kumar Basic Pathology

Treatment

Insulin Therapy (Always Required in T1DM)

• Basal insulin (once or twice daily): long-acting insulins (glargine, detemir, degludec) - provides background coverage
• Bolus/prandial insulin (before meals): rapid-acting insulins (lispro, aspart, glulisine) - controls postmeal glucose spikes
• Total daily dose: typically 0.6-1.0 units/kg/day, divided between basal (~50%) and bolus (~50%)

• Insulin pumps (CSII - Continuous Subcutaneous Insulin Infusion): deliver programmed basal rates + patient-triggered boluses; reduce hypoglycemia and HbA1c
• Continuous Glucose Monitors (CGM): provide real-time glucose readings with alerts; when combined with pumps = "closed-loop" or "artificial pancreas" systems
• In 2021, the FDA approved commercial pancreatic islet transplantation (CellTrans) for highly select individuals with severe hypoglycemia unawareness

Glycemic Targets

• HbA1c target: generally <7% (ADA) in adults; <7.5% in pediatric populations
• The landmark Diabetes Control and Complications Trial (DCCT) demonstrated that tight glycemic control significantly reduces risk of microvascular complications (microalbuminuria, retinopathy, neuropathy)
• Current Surgical Therapy 14e; Washington Manual of Medical Therapeutics; Rosen's Emergency Medicine

Chronic Complications

Microvascular (specific to diabetes; directly related to hyperglycemia)

Macrovascular

• Accelerated atherosclerosis: coronary artery disease, stroke, peripheral arterial disease, heart failure
• T1DM patients have significantly elevated cardiovascular mortality
• Washington Manual of Medical Therapeutics; Rosen's Emergency Medicine; Harrison's Principles 22e

Pancreas and Islet Transplantation

• Whole-organ pancreas transplant: established therapy; most commonly performed simultaneously with kidney transplant (SPK) in patients with T1DM and ESRD; can achieve insulin independence
• Islet cell transplantation: FDA-approved since 2021 as a commercial product (CellTrans) for select patients; less invasive but less durable than whole-organ transplant; limited to a few academic centers
• Current Surgical Therapy 14e

Key Summary Points

1. T1DM = autoimmune beta-cell destruction → absolute insulin deficiency
2. Pathogenesis: HLA-DR3/DR4 genetic susceptibility + environmental triggers → loss of T-cell self-tolerance → insulitis → beta-cell destruction
3. Autoantibodies (anti-GAD65, anti-IA2) are diagnostic markers; T-cell cytotoxicity is the effector
4. Presents in childhood/adolescence with polyuria, polydipsia, weight loss; acute crisis is DKA
5. Insulin replacement is lifelong and non-negotiable
6. Tight glycemic control (HbA1c <7%) reduces microvascular complications (proven by DCCT)
7. Associated with other autoimmune diseases (thyroid, adrenal, celiac)
8. Twin concordance ~30-50% confirms both genetic and environmental contributions

Juvenile Diabetes Mellitus - Pediatric Nursing (BSc Nursing)

1. Definition

From a nursing perspective, T1DM is a lifelong condition requiring 24-hour management involving insulin therapy, blood glucose monitoring, diet, activity, and extensive patient/family education.

2. Epidemiology (Nursing Relevance)

• Accounts for 5-10% of all diabetes cases
• Most common type in persons under 20 years of age
• Can occur at any age but peaks at 5-7 years and during puberty (10-14 years)
• Incidence is rising worldwide
• Affects boys and girls equally
• Risk in siblings of affected children: 5-6%; monozygotic twins: ~30-50%

3. Etiology (Causes)

4. Pathophysiology (Simplified for Nursing)

Genetic susceptibility + Environmental trigger
        ↓
Autoimmune T-cell attack on β cells (INSULITIS)
        ↓
Progressive destruction of β cells (takes months to years)
        ↓
>90% β cells destroyed → Absolute insulin deficiency
        ↓
Glucose cannot enter cells → HYPERGLYCEMIA
        ↓
Body breaks down fat → KETONE production → DIABETIC KETOACIDOSIS (DKA)

• Stage 1: β-cell autoimmunity present, blood sugar still normal
• Stage 2: β-cell autoimmunity + impaired glucose tolerance (presymptomatic)
• Stage 3: Overt hyperglycemia + symptoms appear
• Robbins & Kumar Basic Pathology

5. Clinical Manifestations in Children

A. Classic Triad ("Three Polys")

B. Other Common Symptoms in Children

• Unexplained weight loss despite eating well
• Fatigue and weakness
• Blurred vision (osmotic changes in lens)
• Enuresis (bedwetting) - new onset in previously dry child is a red flag
• Recurrent infections (fungal infections, skin infections)
• Irritability, mood changes, poor school performance

C. Diabetic Ketoacidosis (DKA) - Emergency Presentation

Nursing Alert: Any child presenting with vomiting + abdominal pain + rapid breathing - ALWAYS check blood glucose and urine ketones. DKA is life-threatening.

6. Nursing Assessment (Head-to-Toe)

History Collection

• Onset and duration of symptoms (polydipsia, polyuria, weight loss)
• Family history of diabetes or autoimmune disease
• Recent viral illness
• Dietary habits, growth chart, developmental milestones
• Previous health history, immunization status

Physical Assessment

Diagnostic Assessment

7. Nursing Diagnoses (NANDA)

1. Deficient Fluid Volume related to osmotic diuresis and vomiting (DKA)
2. Imbalanced Nutrition: Less Than Body Requirements related to lack of insulin and cellular glucose starvation
3. Risk for Unstable Blood Glucose Level related to inadequate insulin, diet non-compliance, illness
4. Risk for Infection related to hyperglycemia impairing immune function
5. Deficient Knowledge (child and family) related to new diagnosis and insulin management
6. Anxiety/Fear (child and parents) related to new diagnosis and lifelong management
7. Non-compliance (Risk for) related to child's developmental stage and lifestyle factors
8. Risk for Injury related to hypoglycemia episodes

8. Nursing Interventions

A. Insulin Administration (Most Critical Nursing Action)

• Basal insulin once daily (long-acting) = background coverage
• Bolus insulin before each meal (rapid-acting) = controls post-meal spikes

• Rotate injection sites (abdomen, outer thigh, upper arm, buttocks) - document site rotation
• Injection sites in children: outer thigh and buttocks preferred (more subcutaneous fat)
• Inject at 90° angle (if adequate fat); at 45° in thin children
• Never massage injection site (alters absorption rate)
• Keep insulin vials at room temperature (in use); store extra in refrigerator (never freeze)
• Check insulin appearance: clear for regular/long-acting; cloudy for NPH (roll gently, never shake)
• Two-nurse verification recommended before giving insulin

B. Blood Glucose Monitoring

• Teach children and parents to perform self-monitoring of blood glucose (SMBG)
• Typical frequency: 4-6 times/day (before meals, 2 hours after meals, at bedtime, overnight)
• Target glucose ranges for children:

• Continuous Glucose Monitor (CGM): teach parents how to use; alerts for high/low glucose
• Document all readings in a glucose log

C. Management of Hypoglycemia (Low Blood Sugar)

Most common acute complication in children on insulin. Must be recognized and treated immediately.

1. Give 15 grams of fast-acting carbohydrate (4 oz juice, 3-4 glucose tablets, 1 tbsp sugar)
2. Wait 15 minutes, recheck blood glucose
3. If still < 70 mg/dL, repeat
4. Once glucose normalizes, give a small snack (complex carb + protein)
5. Never give food/liquid to unconscious child - give IV Dextrose (D25W or D50W) or IM Glucagon

Nursing Alert: Keep glucagon emergency kit available at all times. Teach parents and school nurse how to administer it.

D. Management of DKA (Emergency Care)

1. Establish IV access - large-bore cannula
2. IV fluid resuscitation: Normal saline (0.9% NaCl) - correct dehydration cautiously in children (risk of cerebral edema)
3. Insulin infusion: Regular insulin IV infusion at 0.05-0.1 units/kg/hr (never give bolus in DKA)
4. Monitor electrolytes: K+ levels carefully - insulin shifts K+ into cells, causing hypokalemia; replace potassium as needed
5. ABG monitoring: Watch pH and bicarbonate levels
6. Hourly vital signs + neuro checks: Watch for cerebral edema (headache, change in consciousness) - give mannitol if suspected
7. Urine output monitoring: Insert catheter; target > 1 mL/kg/hr
8. When blood glucose reaches 200-250 mg/dL: Add dextrose to IV fluids (to prevent hypoglycemia while continuing insulin)
9. Transition to subcutaneous insulin once child is eating and ketones are cleared

E. Nutritional Management

• Diet planned by a registered dietitian with carbohydrate counting
• Carbohydrate counting is the key skill - insulin dose is matched to carbohydrate intake
• Regular meal schedule - no skipping meals; consistent carbohydrate intake
• Encourage fiber-rich foods, whole grains, lean protein
• Limit simple sugars, sweetened beverages
• Adjust diet for physical activity (additional snacks before exercise)
• No food should be completely forbidden - teach moderation and balance
• School meals: coordinate with school nurse; ensure child has snacks available

F. Exercise and Activity

• Exercise is beneficial and encouraged
• Monitor blood glucose before, during, and after exercise
• If glucose < 100 mg/dL before exercise - give carbohydrate snack first
• Carry fast-acting sugar (glucose tablets/juice) during exercise
• Reduce insulin dose before planned vigorous exercise (as per physician orders)
• Avoid strenuous exercise during ketoacidosis

9. Patient and Family Education (Priority Nursing Responsibility)

Topics to Teach:

• How to measure blood glucose (glucometer use, CGM)
• How to draw and inject insulin correctly
• Recognition and treatment of hypoglycemia and hyperglycemia
• Sick-day rules (never stop insulin; check glucose/ketones more frequently when ill)
• When to call the doctor/go to hospital
• Carbohydrate counting and meal planning
• Foot and skin care (long-term)
• Importance of wearing medical ID bracelet/tag

• Toddler/Preschool (1-5 years): Parents handle all management; child should be able to say "I have diabetes" and "I need sugar"
• School age (6-12 years): Teach child to recognize symptoms of hypoglycemia; can assist with glucose testing; gradually learn insulin injection with supervision
• Adolescent (13-18 years): Can independently manage glucose monitoring and insulin; teach impact of puberty (hormones raise insulin requirements), alcohol risks, peer pressure, sexual health
• Encourage independence gradually while maintaining parental oversight

• Provide school nurse with a Diabetes Medical Management Plan (DMMP)
• Ensure teachers know symptoms of low/high blood sugar
• Child should be allowed to check blood sugar and take insulin at school
• Keep emergency glucagon kit at school

10. Complications - Nursing Monitoring

Acute Complications

Chronic Complications (Long-term Monitoring)

Tight glycemic control (HbA1c < 7.5%) is proven to delay and reduce all microvascular complications - reinforce this to families at every visit (DCCT trial evidence).

11. Psychological and Developmental Considerations

• Diabetes is a psychosocial burden for both child and family
• Children may feel different from peers, leading to poor self-esteem, depression
• Diabetes burnout is common in adolescents - non-compliance with insulin/monitoring
• Screen for depression and anxiety at every visit
• Encourage age-appropriate independence and normal social activities
• Diabetic camps: strongly recommended - children socialize with peers who have T1DM
• Refer to counselor or psychologist if needed
• Siblings may feel neglected due to attention on the diabetic child - address family dynamics

12. Special Situations in Pediatric Nursing

13. Quick Summary Table for Exams

Important Nursing Principle: The nurse is not just a care-giver in T1DM - the nurse is an educator, coordinator, and advocate. Teaching the child and family to self-manage safely is the foundation of pediatric diabetic nursing care.